Peptide
Receptor Radionuclide and Octreotide: A Novel Approach for Metastatic Tumor - Induced Osteomalacia JES May 3, 2017 Abilash Nair, Semanti Chakraborty, Pramila Dharmshaktu, Nikhil Tandon, Yashdeep Gupta, Rajesh Khadgawat, Puthiyaveettil Khadar Jabbar, Chandra Sekhar Bal, Shipra Agarwal, and Mohd Ashraf Ganie Octreotide can be used as an adjunctive therapy to increase phosphorus levels in patients with tumor - induced osteomalacia.